U.S. Gene Synthesis Market Size & Outlook, 2022-2030
U.S. gene synthesis market, 2018-2030 (US$M)
Related Markets
U.S. gene synthesis market highlights
- The U.S. gene synthesis market generated a revenue of USD 599.3 million in 2022 and is expected to reach USD 1,964.3 million by 2030.
- The U.S. market is expected to grow at a CAGR of 16% from 2023 to 2030.
- In terms of segment, solid-phase synthesis was the largest revenue generating method in 2022.
- PCR-based Enzyme Synthesis is the most lucrative method segment registering the fastest growth during the forecast period.
Gene synthesis market data book summary
| Market revenue in 2022 | USD 599.3 million |
| Market revenue in 2030 | USD 1,964.3 million |
| Growth rate | 16% (CAGR from 2022 to 2030) |
| Largest segment | Solid-phase synthesis |
| Fastest growing segment | PCR-based Enzyme Synthesis |
| Historical data | 2018 - 2021 |
| Base year | 2022 |
| Forecast period | 2023 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Solid-phase Synthesis, Chip-based Synthesis, PCR-based Enzyme Synthesis |
| Key market players worldwide | Genscript Biotech Corp Class H, Brooks Automation, Twist Bioscience Corp, ProteoGenix, Biomatik Corporation, Thermo Fisher Scientific Inc, Integrated DNA Technologies, Origene Technologies |
Other key industry trends
- In terms of revenue, U.S. accounted for 34.1% of the global gene synthesis market in 2022.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. gene synthesis market is projected to lead the regional market in terms of revenue in 2030.
- U.S. is the fastest growing regional market in North America and is projected to reach USD 1,964.3 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Gene Synthesis Market Scope
Gene Synthesis Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
U.S. gene synthesis market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to gene synthesis market will help companies and investors design strategic landscapes.
Solid-phase synthesis was the largest segment with a revenue share of 35.64% in 2022. Horizon Databook has segmented the U.S. gene synthesis market based on solid-phase synthesis, chip-based synthesis, pcr-based enzyme synthesis covering the revenue growth of each sub-segment from 2018 to 2030.
U.S.-based companies continue to offer advanced gene synthesis products and services, which drives the market for gene synthesis in the country. For instance, Synbio Technologies LLC, a New Jerseybased company offers a comprehensive portfolio of gene synthesis services to fulfill a customer’s DNA manufacturing needs.
The company also offers add-on services, such as cloning, mutagenesis, plasmid preparation, and protein expression & purification. Furthermore, U.S.-based players and organizations are continuously involved in high-quality biotechnology & pharmaceutical research, which also aids market growth.
The country’s strong performance is strengthened by its highly efficient institutions such as the University of Texas at Austin, Massachusetts Institute of Technology, and more. Wide application of gene synthesis has garnered the interest of various companies and scientific communities.
Reasons to subscribe to U.S. gene synthesis market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. gene synthesis market databook
-
Our clientele includes a mix of gene synthesis market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. gene synthesis market, including forecasts for subscribers. This country databook contains high-level insights into U.S. gene synthesis market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
U.S. gene synthesis market report size, by method, 2018-2030 (US$M)
U.S. Gene Synthesis Market Share, 2022 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
